- Home
- HOVR vs ANVS Comparison
HOVR vs ANVS Comparison
Compare HOVR & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOVR | ANVS |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.1M | 53.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HOVR | ANVS |
|---|---|---|
| Price | $1.77 | $4.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $6.50 | ★ $13.50 |
| AVG Volume (30 Days) | 1.1M | ★ 3.9M |
| Earning Date | 01-13-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $55.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $1.11 |
| 52 Week High | $4.18 | $6.37 |
Technical Indicators
Market Signals| Indicator | HOVR | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 47.47 | 68.85 |
| Support Level | $1.16 | $4.01 |
| Resistance Level | $1.69 | $4.82 |
| Average True Range (ATR) | 0.17 | 0.66 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 77.22 | 69.78 |
Price Performance
Historical ComparisonAbout HOVR New Horizon Aircraft Ltd.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.